Evidence map›Paper›PMID 32523701›Full record

Article2d materials2020

MoS

Chawina De-Eknamkul, Xingwang Zhang, Meng-Qiang Zhao, Wenzhuo Huang, Renyu Liu, A T Charlie Johnson, Ertugrul Cubukcu

Open access · greenAbstract read
In one paragraph

Article in 2d materials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chawina De-EknamkulDepartment of NanoEngineering, University of California, San Diego, La Jolla, CA 92093-0448, United States of America.ORCID 0000-0001-7776-9537
Xingwang ZhangDepartment of NanoEngineering, University of California, San Diego, La Jolla, CA 92093-0448, United States of America.
Meng-Qiang ZhaoDepartment of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, United States of America.
Wenzhuo HuangDepartment of Electrical and Computer Engineering, University of California, San Diego, La Jolla, CA 92093-0407, United States of America.
Renyu LiuDepartment of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States of America.
A T Charlie JohnsonDepartment of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, United States of America.ORCID 0000-0002-5402-1224
Ertugrul CubukcuDepartment of NanoEngineering, University of California, San Diego, La Jolla, CA 92093-0448, United States of America.
University of California San Diego · USUniversity of Pennsylvania · US

Funding

Water soluble variants of the human mu opioid receptorR01GM111421 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI LIU, RENYU · 2014 to 2018
$1.7M
NIGMS NIH HHS R01 GM111421
6 · The paper itself

Abstract

Owing to their unique electrical and optical properties, two-dimensional transition metal dichalcogenides have been extensively studied for their potential applications in biosensing. However, simultaneous utilization of both optical and electrical properties has been overlooked, yet it can offer enhanced accuracy and detection versitility. Here, we demonstrate a dual-mode optoelectronic biosensor based on monolayer molybdenum disulfide (MoS

Indexed as

field-effect transistormolybdenum disulfidemultimodal biosensormu-opioid receptorphotonic crystaltransition metal dichalcogenides

Identifiers

PMID32523701
PMCPMC7286605
OpenAlexW2991087261

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.